相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。IncA/C Plasmid Carrying blaNDM-1, blaCMY-16, and fosA3 in a Salmonella enterica Serovar Corvallis Strain Isolated from a Migratory Wild Bird in Germany
L. Villa et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Complete Nucleotide Sequences of blaCTX-M-Harboring IncF Plasmids from Community-Associated Escherichia coli Strains in the United States
Jun-Jie Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Dissemination of a clone carrying a fosA3-harbouring plasmid mediates high fosfomycin resistance rate of KPC-producing Klebsiella pneumoniae in China
Yan Jiang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Characterization of fosA5, a new plasmid-mediated fosfomycin resistance gene in Escherichia coli
Y. Ma et al.
LETTERS IN APPLIED MICROBIOLOGY (2015)
Characterization of Fosfomycin Resistant Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolates from Human and Pig in Taiwan
Sung-Pin Tseng et al.
PLOS ONE (2015)
Antimicrobial Susceptibility and Molecular Mechanisms of Fosfomycin Resistance in Clinical Escherichia coli Isolates in Mainland China
Ya Li et al.
PLOS ONE (2015)
Fosfomycin Resistance in Escherichia coli, Pennsylvania, USA
Hind Alrowais et al.
EMERGING INFECTIOUS DISEASES (2015)
In Vitro Activity of Fosfomycin against Escherichia coli Isolated from Patients with Urinary Tract Infections in Canada as Part of the CANWARD Surveillance Study
James A. Karlowsky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
The First NDM Metallo-β-Lactamase-Producing Enterobacteriaceae Isolate in Poland: Evolution of IncFII-Type Plasmids Carrying the blaNDM-1 Gene
J. Fiett et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Whole-Genome Assembly of Klebsiella pneumoniae Coproducing NDM-1 and OXA-232 Carbapenemases Using Single-Molecule, Real-Time Sequencing
Yohei Doi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Genome Sequencing of an Extended Series of NDM-Producing Klebsiella pneumoniae Isolates from Neonatal Infections in a Nepali Hospital Characterizes the Extent of Community- versus Hospital-Associated Transmission in an Endemic Setting
N. Stoesser et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Practical Agar-Based Disk Potentiation Test for Detection of Fosfomycin-Nonsusceptible Escherichia coli Clinical Isolates Producing Glutathione S-Transferases
Genki Nakamura et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Susceptibility to Alternative Oral Antimicrobial Agents in Relation to Sequence Type ST131 Status and Coresistance Phenotype among Recent Escherichia coli Isolates from US Veterans
James R. Johnson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Prevalence and molecular epidemiology of plasmid-mediated fosfomycin resistance genes among blood and urinary Escherichia coli isolates
Pak-Leung Ho et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2013)
Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance
Alfredo Castaneda-Garcia et al.
ANTIBIOTICS-BASEL (2013)
Dissemination of the Fosfomycin Resistance Gene fosA3 with CTX-M β-Lactamase Genes and rmtB Carried on IncFII Plasmids among Escherichia coli Isolates from Pets in China
Jianxia Hou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Prevalence of acquired fosfomycin resistance among extended-spectrum -lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3
So-Young Lee et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Characterization of an IncFII Plasmid Encoding NDM-1 from Escherichia coli ST131
Remy A. Bonnin et al.
PLOS ONE (2012)
Antimicrobial Susceptibilities of Commonly Encountered Bacterial Isolates to Fosfomycin Determined by Agar Dilution and Disk Diffusion Methods
Ching-Lan Lu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
Kalpana Gupta et al.
CLINICAL INFECTIOUS DISEASES (2011)
What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline
David M. Livermore et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
In Vitro Activity of Fosfomycin against bla(KPC)-Containing Klebsiella pneumoniae Isolates, Including Those Nonsusceptible to Tigecycline and/or Colistin
Andrea Endimiani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Prevalence of Fosfomycin Resistance among CTX-M-Producing Escherichia coli Clinical Isolates in Japan and Identification of Novel Plasmid-Mediated Fosfomycin-Modifying Enzymes
Jun-ichi Wachino et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Antimicrobial susceptibility of Gram-negative nonurinary bacteria to fosfomycin and other antimicrobials
George Samonis et al.
FUTURE MICROBIOLOGY (2010)
Molecular Epidemiology of CTX-M-Producing Escherichia coli Isolates at a Tertiary Medical Center in Western Pennsylvania
Hanna E. Sidjabat et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Complete nucleotide sequence of pKP96, a 67 850 bp multiresistance plasmid encoding qnrA1, aac(6')-Ib-cr and blaCTX-M-24 from Klebsiella pneumoniae
Ping Shen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Phosphonoformate: A minimal transition state analogue inhibitor of the fosfomycin resistance protein, FosA
RE Rigsby et al.
BIOCHEMISTRY (2004)
分享论文
